Pharmaceutical Services Negotiating Committee (PSNC)

By Chief Executive Janet Morrison Spring is supposedly the season for new beginnings. But how are community pharmacy owners supposed to have any time or energy for that? So many businesses are in a desperate position – both financially and operationally – as the cost of living, workforce and primary care crises continue to impact on our sector. The consequences are devastating. So it’s little wonder that the reaction to the Government’s Primary Care Access Plan from some of you has been anger.

PSNC has today (30th May) become Community Pharmacy England, with a strengthened commitment to championing community pharmacies and engaging with the sector. Community pharmacies are under immense pressures and need a strong and powerful voice to represent them to Government and the NHS. We are that voice, and we are currently working hard through the negotiations on the Primary Care Access Plan to make the most of the associated £645m investment in the sector.

Community Pharmacy England has this week launched, with new branding designed to help community pharmacy to be taken even more seriously right up to the highest levels. The rebranding comes alongside a commitment to engaging better with and building stronger relationships with pharmacy owners – our members.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 June 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size.

Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies.

Dispensing & Supply|Headline|Shortages National Patient Safety Alert: Shortage of pyridostigmine 60mg tablets National Patient Safety Alert Reference Number: NatPSA/2023/006/DHSC Date issued: 24th May 2023 Brief description of the problem Pyridostigmine 60mg tablets are out of stock, resupply is expected week commencing 12 June 2023.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Bromfenac (Yellox® ) 900 micrograms/ml eye drops. MSN/2023/054 Tier 2 – medium impact Date of issue 25th May 2023 Bromfenac (Yellox®) 900 micrograms/ml eye drops are out of stock until w/c 3 July 2023. Ketorolac trometamol 0.5% w/v eye drops remain available and will be able to support an increase in demand. Unlicensed supplies of bromfenac 900 micrograms/ml eye drops may be sourced, lead times vary.

Update 25th May 2023: Norditropin® Flexpro® 5mg will be out of stock from early August until at least September 2023. Norditropin® Flexpro® 10mg pens will be out of stock from mid-July until at least September 2023. Norditropin® Flexpro® 15mg pens will be out of stock from mid-June until at least September 2023. Other alternative somatropin products remain available but may require a change in formulation and/or dosing regimen.

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies.

The Department of Health and Social Care, the UK Health Security Agency and NHS England have jointly published the national flu vaccination programme letter today (25th May 2023) for the 2023/24 season. Eligible cohorts The letter confirms the eligible cohorts for the 2023/24 season and the vaccines which will be reimbursable under the Community Pharmacy Seasonal Influenza Vaccination Advanced Service (Flu Vaccination Service).